Literature DB >> 22233358

The impact of apheresis platelet manipulation on corrected count increment.

Matthew Karafin1, Alice K Fuller, William J Savage, Karen E King, Paul M Ness, Aaron A R Tobian.   

Abstract

BACKGROUND: Concentrating and washing apheresis platelets (APs) substantially reduce the number of allergic transfusion reactions likely due to removal of plasma. However, these processes may damage platelets (PLTs). This study evaluated whether concentrating or washing APs decrease the corrected count increment (CCI). STUDY DESIGN AND METHODS: This retrospective study evaluated individuals who initially received unmanipulated APs and subsequently received concentrated and/or washed APs at a large university hospital between 1998 and 2009. Concentrated units were prepared by reducing the plasma volume of APs by a goal of more than 67%. Washed units were prepared by washing the APs with 1 L of normal saline. The CCI (PLTs [×10(6)] × m(2)/L) for all transfusions was calculated. Hypothesis testing was performed with t tests for continuous variables and chi-square tests for dichotomous variables.
RESULTS: We evaluated 121 individuals: 46 patients who received unmanipulated, concentrated, and then washed APs; 59 patients who received unmanipulated and then concentrated APs; and 16 patients who received unmanipulated and then washed APs. Patient demographics were similar among the three groups. The mean CCI for unmanipulated AP transfusions at 0 to 2 hours posttransfusion was significantly higher than concentrated and washed PLT transfusions (p<0.001). When accounting for PLT loss due to manipulation, concentrating APs did not impact the CCI. However, the CCI remained significantly lower for washed products at all time points after transfusion (40.7% mean reduction at 20-24 hr, p<0.001).
CONCLUSIONS: Washing APs significantly reduces PLT count recovery and survival, as demonstrated by a significantly reduced CCI.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2012        PMID: 22233358      PMCID: PMC3325359          DOI: 10.1111/j.1537-2995.2011.03476.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  18 in total

1.  Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.

Authors:  J de Wildt-Eggen; S Nauta; J G Schrijver; M van Marwijk Kooy; M Bins; H C van Prooijen
Journal:  Transfusion       Date:  2000-04       Impact factor: 3.157

2.  Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction.

Authors:  Aaron A R Tobian; William J Savage; Daniel J Tisch; Sandra Thoman; Karen E King; Paul M Ness
Journal:  Transfusion       Date:  2011-01-07       Impact factor: 3.157

3.  Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions.

Authors:  William J Savage; Jessica H Savage; Aaron A R Tobian; Chris Thoburn; Robert G Hamilton; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2011-08-29       Impact factor: 3.157

4.  Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert G Hamilton; Paul M Ness
Journal:  Transfusion       Date:  2011-05-13       Impact factor: 3.157

5.  Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes.

Authors:  William J Savage; Aaron A Tobian; Alice K Fuller; Robert A Wood; Karen E King; Paul M Ness
Journal:  Transfusion       Date:  2011-01-07       Impact factor: 3.157

6.  Dose of prophylactic platelet transfusions and prevention of hemorrhage.

Authors:  Sherrill J Slichter; Richard M Kaufman; Susan F Assmann; Jeffrey McCullough; Darrell J Triulzi; Ronald G Strauss; Terry B Gernsheimer; Paul M Ness; Mark E Brecher; Cassandra D Josephson; Barbara A Konkle; Robert D Woodson; Thomas L Ortel; Christopher D Hillyer; Donna L Skerrett; Keith R McCrae; Steven R Sloan; Lynne Uhl; James N George; Victor M Aquino; Catherine S Manno; Janice G McFarland; John R Hess; Cindy Leissinger; Suzanne Granger
Journal:  N Engl J Med       Date:  2010-02-18       Impact factor: 91.245

7.  Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol).

Authors:  Hiroshi Azuma; Junichi Hirayama; Mitsuaki Akino; Reiko Miura; Yoshio Kiyama; Kiyotoshi Imai; Masaharu Kasai; Kazuki Koizumi; Yasutaka Kakinoki; Yusuke Makiguchi; Koji Kubo; Yoshiko Atsuta; Mitsuhiro Fujihara; Chihiro Homma; Sadamitsu Yamamoto; Toshiaki Kato; Hisami Ikeda
Journal:  Transfusion       Date:  2008-09-16       Impact factor: 3.157

8.  Platelet function testing to assess effectiveness of platelet transfusion therapy.

Authors:  Mohamed E Salama; Sundara Raman; Mary Jo Drew; Majdi Abdel-Raheem; Muhammad N Mahmood
Journal:  Transfus Apher Sci       Date:  2004-04       Impact factor: 1.764

9.  Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial.

Authors:  Helen Enright; Kathryn Davis; Terry Gernsheimer; Jeffrey J McCullough; Robert Woodson; Sherrill J Slichter
Journal:  Transfusion       Date:  2003-11       Impact factor: 3.157

10.  Allergic transfusion reactions: an evaluation of 273 consecutive reactions.

Authors:  Ronald E Domen; Gerald A Hoeltge
Journal:  Arch Pathol Lab Med       Date:  2003-03       Impact factor: 5.534

View more
  12 in total

Review 1.  Does ABO and RhD matching matter for platelet transfusion?

Authors:  Nancy M Dunbar
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 2.  Scratching the surface of allergic transfusion reactions.

Authors:  William J Savage; Aaron A R Tobian; Jessica H Savage; Robert A Wood; John T Schroeder; Paul M Ness
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

3.  Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution.

Authors:  Hermógenes Fernández-Muñoz; Cristina Castilla-Llorente; Eva M Plaza; Cristina Martínez-Millán; Inmaculada Heras; Pastora Iniesta; María L Amigo; Francisca Ferrer-Marin; María J Candela; María L Lozano; Vicente Vicente; José Rivera
Journal:  Blood Transfus       Date:  2017-04-13       Impact factor: 3.443

4.  The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).

Authors:  Aaron A R Tobian; Alice K Fuller; Kristin Uglik; Daniel J Tisch; Prabhakar D Borge; Richard J Benjamin; Paul M Ness; Karen E King
Journal:  Transfusion       Date:  2013-11-19       Impact factor: 3.157

5.  What Laboratory Tests and Physiologic Triggers Should Guide the Decision to Administer a Platelet or Plasma Transfusion in Critically Ill Children and What Product Attributes Are Optimal to Guide Specific Product Selection? From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.

Authors:  Meghan Delaney; Oliver Karam; Lani Lieberman; Katherine Steffen; Jennifer A Muszynski; Ruchika Goel; Scot T Bateman; Robert I Parker; Marianne E Nellis; Kenneth E Remy
Journal:  Pediatr Crit Care Med       Date:  2022-01-01       Impact factor: 3.971

6.  Comparison of Quality and Efficacy of Apheresis Platelets Stored in Platelet Additive Solution Vis a Vis Plasma.

Authors:  Debapriya Basu; Sabita Basu; Vivek S Radhakrishnan; Sanjay Bhattacharya; Subhosmito Chakraborty; Subir Sinha; Mammen Chandy
Journal:  Indian J Hematol Blood Transfus       Date:  2021-03-12       Impact factor: 0.915

7.  The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions.

Authors:  Seema Kacker; Paul M Ness; William J Savage; Kevin D Frick; Jeffrey McCullough; Karen E King; Aaron A R Tobian
Journal:  Transfusion       Date:  2013-01-30       Impact factor: 3.157

8.  Recommendations on Selection and Processing of RBC Components for Pediatric Patients From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Nicole D Zantek; Robert I Parker; Leo M van de Watering; Cassandra D Josephson; Scot T Bateman; Stacey L Valentine; Meghan Delaney
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

9.  Quality improvement with platelet additive solution for safer out-of-group platelet transfusions.

Authors:  Maxim Tynuv; Willy A Flegel
Journal:  Immunohematology       Date:  2019-09

Review 10.  Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment.

Authors:  Fumiya Hirayama
Journal:  Br J Haematol       Date:  2012-12-06       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.